UBS Group’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73 | Hold |
108
| – | – | ﹤0.01% | 8702 |
|
|
2025
Q1 | $92 | Hold |
108
| – | – | ﹤0.01% | 8638 |
|
|
2024
Q4 | $89 | Hold |
108
| – | – | ﹤0.01% | 8416 |
|
|
2024
Q3 | $107 | Sell |
108
-57,195
| -100% | -$56.7K | ﹤0.01% | 7935 |
|
|
2024
Q2 | $45.8K | Buy |
57,303
+57,195
| +52,958% | +$45.8K | ﹤0.01% | 5609 |
|
|
2024
Q1 | $130 | Sell |
108
-1,777
| -94% | -$2.14K | ﹤0.01% | 7624 |
|
|
2023
Q4 | $2.98K | Buy |
1,885
+1,777
| +1,645% | +$2.81K | ﹤0.01% | 6814 |
|
|
2023
Q3 | $96 | Hold |
108
| – | – | ﹤0.01% | 7750 |
|
|
2023
Q2 | $130 | Hold |
108
| – | – | ﹤0.01% | 7381 |
|
|
2023
Q1 | $174 | Sell |
108
-1,090
| -91% | -$1.76K | ﹤0.01% | 8056 |
|
|
2022
Q4 | $1.44K | Buy |
+1,198
| New | +$1.44K | ﹤0.01% | 8669 |
|
|
2022
Q3 | – | Sell |
-881
| Closed | -$1K | – | 9519 |
|
|
2022
Q2 | $1K | Buy |
+881
| New | +$1K | ﹤0.01% | 8873 |
|